US2010022631A1PendingUtilityA1

Treatment of hepatic encephalopathy and liver cirrhosis

Assignee: YISSUM RES DEV COPriority: Oct 25, 2006Filed: Apr 24, 2009Published: Jan 28, 2010
Est. expiryOct 25, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61K 31/09A61K 31/232A61K 31/165A61P 1/16A61K 31/658Y02A50/30
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.

Claims

exact text as granted — not AI-modified
1 . A method for prevention, treatment, or both, of hepatic encephalopathy, comprising administering to a subject in need a therapeutically effective amount of a compound selected from the group consisting of D9-tetrahydrocannabinol, cannabidiol and capsaicin. 
     
     
         2 . The method according to  claim 1 , wherein said compound is D9-tetrahydrocannabinol. 
     
     
         3 . The method according to  claim 1 , wherein said compound is administered orally, parenterally, sublingually, or by inhalation. 
     
     
         4 . The method according to  claim 1 , wherein said hepatic encephalopathy is of Type A or Type C. 
     
     
         5 . A method for prevention, treatment, or both, of liver cirrhosis, comprising administering to a subject in need a therapeutically effective amount of a compound selected from the group consisting of capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol. 
     
     
         6 . The method according to  claim 5 , wherein said compound capsaicin. 
     
     
         7 . The method according to  claim 5 , wherein said compound is administered orally, parenterally, sublingually, or by inhalation. 
     
     
         8 . A method according to  claim 1 , wherein said compound is capsaicin. 
     
     
         9 . A method for prevention, treatment, or both, of hepatic encephalopathy, comprising administering to a subject in need a therapeutically effective amount of D9-tetrahydrocannabinol. 
     
     
         10 . A method for prevention, treatment, or both, of hepatic encephalopathy, comprising administering to a subject in need a therapeutically effective amount of capsaicin. 
     
     
         11 . A method for prevention, treatment, or both, of liver cirrhosis comprising administering to a subject in need a therapeutically effective amount of capsaicin.

Join the waitlist — get patent alerts

Track US2010022631A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.